Tag Archives: revive

Automakers ask Congress to revive effort

Although an attempted expansion of the federal EV tax credit has failed—multiple times, in recent years—in a renewed effort, automakers are asking Congress to please try again.

In 2009, Congress set a 200,000-vehicle cap of qualifying vehicles—including plug-in hybrids—for each automaker, and the framework hasn’t changed since then. General Motors and Tesla have already reached that limit, and Toyota is close to it. Once automakers hit that cap, their eligibility for the credit is gradually phased out.

In a letter to Senate and House of Representatives leadership Monday, the CEOs of GM, Toyota, Ford, and Stellantis asked for tax credits to be extended to anyone buying a qualifying vehicle—until a sunset date for all EV products regardless of the automaker.

2022 Ford F-150 Lightning

Automakers reportedly don’t want the cap lifted until “the EV market is more mature,” but didn’t give a specific timeframe. The automakers summed that the credit has allowed companies to offer more affordable products in greater volume, spurring EV adoption. “However, recent economic pressures and supply chain constraints are increasing the cost of manufacturing electrified vehicles which, in turn, puts pressure on the price to consumers,” they argued.

In its current form, the tax credit awards up to $7,500 depending on the size of a vehicle’s battery pack. So in addition to all-electric vehicles, plug-in hybrids like the Toyota RAV4 Prime and Chrysler Pacifica Hybrid qualify.

But in the absence of a proposed revamped and renewed EV tax credit—offering up to $12,500 per vehicle—we’re left with the existing tax credit and its 200,000-unit cap for the foreseeable future. The second quarter after an automaker hits that cap, its tax credit is halved to $3,750, then drops to one-fourth of the full amount ($1,875) two quarters later. It remains at that level for two full calendar quarters after that before disappearing.

2023 Toyota bZ4X Limited AWD

A previous extension of the EV tax credit had bipartisan support but was reportedly cut out of spending bill as part of “extreme resistance” from then-President Trump.

Since then, the EV tax credit expansion has become more politically charged. A version proposed as part of last year’s infrastructure bill was pushed to a reconciliation spending bill that never happened—because of widespread resistance from Republicans and at least one Democratic Senator—West Virginia’s Joe Manchin.

Part of the pushback to that version—which also included a used EV tax credit—was a requirement that EVs be union-made to get the top credit amount. This was opposed by Tesla, Toyota, and Volkswagen, which build (or plan to build) EVs in non-union factories.

This is noteworthy as it represents an allied front that spans those companies that primarily use a unionized American workforce, including GM and Ford, with Toyota, which primarily uses a non-unionized domestic workforce. Will these bridges build an expanded credit? We’ll soon see.

Read original article here

EXCLUSIVE Beijing gives initial nod to revive Ant IPO after crackdown cools-sources

  • Ant aims to file preliminary prospectus as soon as July-sources
  • Ant needs CSRC’s guidance on timing of prospectus filing-source
  • Ant says there is no plan to relaunch its IPO-statement
  • Warburg Pincus valued Ant at $180 bln at end-March-source

HONG KONG, June 9 (Reuters) – China’s central leadership has given billionaire Jack Ma’s Ant Group a tentative green light to revive its initial public offering (IPO), two sources with knowledge of the matter said, in the clearest sign yet Beijing is easing its crackdown on the tech sector.

Ant, an affiliate of Chinese e-commerce behemoth Alibaba Group Holding Ltd (9988.HK), aims to file a preliminary prospectus for the share offering in Shanghai and Hong Kong as early as next month, the sources said, declining to be named due to the sensitivity of the matter.

The fintech giant will need to wait for guidance from the China Securities Regulatory Commission (CSRC) on the specific timing of the prospectus filing, said one of the sources.

Register now for FREE unlimited access to Reuters.com

Register

In a publicly released statement, Ant said there was no plan to relaunch its IPO, without elaborating. It did not respond to Reuters request for comment on whether it had received a green light from Beijing.

The company’s stock market listing was hastily shelved at the behest of Beijing in November 2020. At the time, it was slated to be valued at around $315 billion and planned to raise $37 billion, which would have been a world record.

“Under the guidance of regulators, we are focused on steadily moving forward with our rectification work and do not have any plan to initiate an IPO,” Ant said on its WeChat account late on Thursday.

Neither the CSRC nor China’s State Council Information Office, which handles media queries for central leaders, responded to Reuters’ request for comment.

Ant wants to keep the IPO revival plans low profile pending a formal announcement, after having attracted regulatory glare in its first attempt back in 2020 with the waves the offering created as the world’s largest ever equity float, a separate source with direct knowledge of the matter said.

Chinese authorities pulled the plug on the IPO and cracked down on Ma’s business empire after he gave a speech in Shanghai in October 2020 accusing financial watchdogs of stifling innovation.

The IPO’s derailment marked the start of a regulatory crackdown to rein in China’s huge homegrown technology sector, which spread to other industries, including property and private education, wiping billions off market capitalisations and triggering layoffs at some firms.

With its economy slowing in a politically sensitive year when Xi Jinping is expected to secure an unprecedented third term as party leader, Beijing is looking to loosen it grip on private businesses including tech giants to help it meet a growth target of 5.5%, something economists have said will be hard to reach given COVID-19 lockdowns. read more

“They are rolling back on their crackdown to counterbalance the lockdown they’ve had. Any data out of China lately has been dreadful because of lockdowns and the last thing they want to do is compound that issue. In the next three to six months we are likely to see China’s crackdown unwound,” said David Madden, market analyst at Equiti Capital in London.

A revival of the IPO may also mark a rehabilitation of sorts for Ma, who has been maintaining a low public profile since Beijing swooped.

EASING EFFORTS

Chinese Vice-Premier Liu He last month told tech executives the government supported the development of the sector and will back firms pursuing listings at home and abroad. read more

In another sign of Beijing’s softer stance, China’s ride-hailer Didi Global, which has been under a cybersecurity probe since last year, is in advanced talks to buy a third of a state-backed electric-vehicle maker, Reuters reported on Wednesday.

News of the talks comes after the Wall Street Journal reported on Monday that Chinese regulators are set to conclude their investigations into Didi , which could offer more hope to investors about its recovery. read more

Bloomberg reported earlier on Thursday that Chinese financial regulators had started early stage talks on a potential revival of Ant’s stock market debut, without mentioning a timeline. read more

The top securities regulator had established a team to reassess the share sale plans, Bloomberg reported.

The regulator later said in a statement it had not conducted any assessment or research work regarding an Ant IPO.

The U.S. listed shares of Alibaba, which owns nearly one-third of Ant, were down 7% after earlier rising as much as 7% in pre-market trading on the Bloomberg report.

U.S. private equity firm Warburg Pincus, a big investor in Ant’s 2018 private fundraising, lowered its valuation of Ant to about $180 billion at end-March from $221 billion one year earlier, a separate source said.

The regulators have directed Ant to restructure as a financial rather than tech firm, and sources and analysts have said the financial sector typically carries lower valuations.

Warburg Pincus declined to comment on Thursday.

“The size of Ant and the IPO will have to be smaller than what was planned in 2020 because the market conditions have changed and cannot be compared to now,” said Dickie Wong, executive director of Kingston Securities in Hong Kong.

U.S.-listed shares of Chinese tech and e-commerce firms including Didi and Alibaba have gained this week on hints Beijing’s one-and-a-half year long crackdown may be easing.

Register now for FREE unlimited access to Reuters.com

Register

Reporting by Julie Zhu; Additional reporting by Medha Singh, Abinaya Vijayaraghavan, Scott Murdoch, Kane Wu and Vidya Ranganathan; Editing by Sumeet Chatterjee, Carmel Crimmins, Elaine Hardcastle and David Evans

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

China zero-Covid: 100,000 officials attend emergency State Council meeting to revive economy

The unexpected video teleconference by the State Council was attended by officials across provincial, city and council levels, according to a report in the government-owned Global Times. High-ranking Chinese officials were also present, including Premier Li Keqiang, who urged authorities to take action in sustaining jobs and reducing unemployment.

Li said that in some aspects, the economic impact seen in March and April has surpassed that of 2020 during the initial outbreak of the coronavirus, according to Global Times. He pointed to several indicators including unemployment rates, lower industrial production and cargo transportation.

The premier has become increasingly vocal about the economic downturn in recent weeks, calling the situation “complex and grave” earlier in May — but Wednesday’s comments may paint the grimmest picture yet.
Investment banks are slashing their forecasts for China’s economy this year. Earlier this week, UBS lowered its full-year GDP growth forecast to 3%, citing risks from Beijing’s strict zero-Covid policy. China has said it expects growth of around 5.5% this year. The world’s second biggest economy reported growth of 8.1% last year, and 2.3% in 2020, the slowest pace in decades.

33 new economic measures

The teleconference comes after a State Council executive meeting on Monday where authorities unveiled 33 new economic measures, including increasing tax refunds, extending loans to small businesses, and providing emergency loans to the hard-hit aviation industry, according to government-owned news outlet Xinhua.

Several of the 33 policies also ease Covid curbs — such as lifting restrictions on trucks traveling from low-risk areas.

At the Wednesday meeting, Li urged government departments to implement those 33 measures by the end of May. The State Council will send task forces to 12 provinces starting Thursday to oversee the roll-out of these policies, he added, according to Xinhua.

Throughout the pandemic, China has adhered to a strict zero-Covid policy that aims to stamp out all chains of transmission using border controls, mandatory quarantines, mass testing and snap lockdowns.

But this strategy has been challenged by the highly infectious Omicron variant, which surged across the country earlier this year despite authorities racing to lock down districts and inter-provincial borders.

By mid-May, more than 30 cities were under full or partial lockdown, impacting up to 220 million people nationwide, according to CNN’s calculations. For industries ranging from Big Tech to consumer goods, that’s destroying both supply and demand.

Though some of those cities have since opened back up, the impact of that disruption is still being felt, with unemployment surging to the highest level since the initial coronavirus outbreak in early 2020.

Many companies have been forced to suspend operations, including automakers Tesla and Volkswagen. Airbnb is the latest multinational firm to pull out, with the home-sharing company announcing this past week that it would shut down its listings in China.

There isn’t a clear end in sight to the crisis, with authorities still struggling to contain the spread of the virus and top leaders insisting on pushing forward with zero-Covid.

On Monday, the national capital Beijing — which has also seen cases creep up over the last few weeks — saw seven districts put under partial lockdown, affecting nearly 14 million residents. The city’s two largest districts, Chaoyang and Haidian, were included — forcing the closure of all non-essential businesses including shopping malls, gyms and entertainment venues.

Read original article here

Utah scientists revive cells in human donor eyes, transforming brain and vision research

Fatima Abbas and Frans Vinberg are scientists at the John A. Moran Eye Center at the University of Utah. The pair have published a study showing how they were able to revive light-sensing neuron cells in organ donor eyes and restore communication between them as part of a series of discoveries that stand to transform brain and vision research. (John A. Moran Eye Center at the University of Utah)

Estimated read time: 3-4 minutes

SALT LAKE CITY — A team of researchers at the University of Utah’s John A. Moran Eye Center have succeeded in reviving neurons and communication in human donor eyes, which they said could transform brain and vision research.

This study, they said, will benefit research on other neuronal tissues in the central nervous system and help researchers better understand neurodegenerative diseases, like macular degeneration.

“We were able to wake up photoreceptor cells in the human macula, which is the part of the retina responsible for our central vision and our ability to see fine detail and color,” said Moran Eye Center scientist Fatima Abbas, lead author of a study published on Wednesday in Nature.

Abbas said age-related macular degeneration, which leads to blindness, affects about 10% of the population.

“Just being able to take these donor eyes and understand how the retina works in humans, specifically, and what’s going wrong in these diseases is a huge thing,” Abbas said.

She explained that in donor eyes obtained up to five hours after the death of the donor, cells respond to bright light, colored light and dim light flashes, but they could not communicate with other retina cells. Researchers determined that this loss of communication stemmed from oxygen deprivation.

To solve this issue, they procured donor eyes within 20 minutes of a donor’s death and designed a transportation unit that could restore oxygenation and nutrients to donor eyes.

Frans Vinberg, a Moran Eye Center scientist, said they were able to make retinal cells communicate as they do in living eyes.

“Past studies have restored very limited electrical activity in organ donor eyes, but this has never been achieved in the macula, and never to the extent we have now demonstrated,” Vinberg said.

He said people are living longer now, and that means more people are dealing with retinal neurodegenerative diseases that lead to blindness.

“If these neurons die, it’s hard to imagine how you can revive them,” he said.

Vinberg said this approach, using human donor eyes, reduces research costs compared to using nonhuman primates, and also ensures results will apply to humans. He said mice are often used for vision research, but they do not have a macula. Through this study they established an approach to reviving the neural tissue in the back of the eye.

“The scientific community can now study human vision in ways that just aren’t possible with laboratory animals. … We hope this will motivate organ donor societies, organ donors and eye banks by helping them understand the exciting new possibilities this type of research offers,” Vinberg said.

He said they produced retinal patches that are fully functional.

“We are basically encouraging other scientists to start to obtain human neural tissue and start to really study and understand how human neurons work,” Vinberg said.

Scripps Research associate professor Dr. Anne Hanneken, who is also a retinal surgeon, said this ability to create viable patches of human retinal tissue will help treat blinding diseases.

“Going forward, we’ll be able to use this approach to develop treatments to improve vision and light signaling in eyes with macular diseases, such as age-related macular degeneration,” Hanneken said.

A University of Utah Health press release explained that this study joins others that question “the irreversible nature of death,” since death is partly defined with a loss of neuronal activity.

Photos

Emily Ashcraft joined KSL.com as a reporter in 2021. She covers courts and legal affairs, as well as health, faith and religion news.

More stories you may be interested in

Read original article here

DOJ says it will appeal to revive mask mandate — if the CDC determines it’s still needed

“The Department of Justice and the Centers for Disease Control and Prevention disagree with the district court’s decision and will appeal, subject to CDC’s conclusion that the order remains necessary for public health,” spokesman Anthony Coley said in a statement.

“The Department continues to believe that the order requiring masking in the transportation corridor is a valid exercise of the authority Congress has given CDC to protect the public health. That is an important authority the Department will continue to work to preserve,” Coley said.

Before the mandate had been struck down, the Biden administration had extended the requirement through May 3, which required masks to be worn aboard public transit, on planes, on trains and inside airports. The CDC was set to assess whether the mandate was still needed until May 3, and Coley said any appeal would come after that date.

“If CDC concludes that a mandatory order remains necessary for the public’s health after that assessment, the Department of Justice will appeal the district court’s decision,” Coley said.

The move comes after the Justice Department had spent much of the last day considering whether to fight a court decision that caught much of the administration, airline industry, local public transit departments and everyday Americans off-guard. An appeal would mean that the administration would head to a higher court to extend the mandate — despite the fact that many airlines and public transit systems have already decided to make masks optional following the court ruling.

If an appeal happens, it would be risky move that could limit the government’s ability to make similar mandates in the future. If the 11th Circuit — which oversees appellate challenges from Florida — upholds the ruling striking down the mandate, it would be precedent for all the other federal courts in that circuit, which covers the Southeast. A Supreme Court ruling upholding the decision to strike down the mandate would make the judge’s conclusions about CDC authority binding nationwide.

Masks aboard Air Force One

Earlier Tuesday, President Joe Biden said he wasn’t sure if his administration would appeal the decision.

When asked in New Hampshire if he wanted the Justice Department to appeal the new mask ruling, Biden said, “I haven’t spoken to the CDC yet.” And when later pressed on the trip about whether there would be an appeal, Biden repeated, “I haven’t gotten any brief from my CDC. I don’t know. We’re following the science.”

Health and Human Services Secretary Xavier Becerra had earlier suggested on Tuesday that such a move was likely.

“We are right now in the process of deciding, and we likely will appeal that ruling. Stay tuned,” Becerra said at a news conference with Nevada Gov. Steve Sisolak.

The evolving situation was on display Tuesday as passengers on Biden’s trip aboard Air Force One to New Hampshire were required to wear masks while, at the same time, commercial airline passengers across the United States were stepping into plane cabins with the option to forgo a mask. The President boarded the aircraft Tuesday afternoon sporting a black mask.

But despite the rules on Air Force One, Biden told reporters upon his arrival in New Hampshire that Americans must make their own decisions on whether to wear masks on planes still, saying, “That’s up to them.”

Biden and his team caught off-guard by judge’s ruling

Administration officials had been caught by surprise when the judge in Florida struck down the requirement, which had been in place for 441 days. Suddenly, a decision administration officials had been contemplating for weeks — whether American travelers must wear masks — was made urgent and complicated by US District Judge Kathryn Kimball Mizelle, who was selected by Biden’s predecessor, Donald Trump.

The order was parsed by lawyers at the White House, Department of Justice and the Department of Homeland Security, which oversees the agency that had been responsible for enforcing the rules. As they digested the 59-page ruling, it wasn’t clear whether passengers sitting in airports or aboard airplanes at 30,000 feet could remove their face coverings without running afoul of federal rules.

Airlines, which had been lobbying the administration for weeks to lift the mandates, sought guidance from the government on what exactly they should tell crews and passengers, whose phones were lighting up with news of the ruling.

And in the hours after the judge’s decision on Monday, White House press secretary Jen Psaki was unable to say whether a federal mask mandate for travelers remained in place.

“We’re continuing to recommend people wear masks. I don’t have any update,” Psaki said when asked whether the mask mandate is still in place for travelers boarding their flights Monday night.

But after a few hours of deliberation, administration lawyers determined the judge’s order meant the mask mandate wasn’t in effect — meaning the government couldn’t enforce it. The CDC emphasized that it was not enforcing the ruling in a subsequent statement to CNN on Tuesday.

Since the ruling and the administration’s subsequent guidance relaying that the mandate could not be enforced, several US airlines, some public transit authorities, Uber, Lyft and Amtrak have all announced that masks were no longer required for passengers.

The White House on Tuesday also pushed back on one of those companies, Delta Air Lines, after the company referred to Covid-19 as an “ordinary seasonal virus” in its post announcing that masks are optional on its flights.

The original post from Delta read: “We are relieved to see the U.S. mask mandate lift to facilitate global travel and COVID-19 has transitioned to an ordinary seasonal virus.”

A White House spokesman for Covid-related issues, Kevin Munoz, replied, “COVID is not an ‘ordinary seasonal virus'” and linked to Biden’s 100-page Covid preparedness plan.

Delta subsequently removed the reference to “ordinary seasonal virus” from its post.

Competing political interests over whether to mask up

If the White House was disappointed in the turn of events, scenes of air passengers gleefully removing their masks midair illustrated the complex emotions surrounding the moment.

Mask mandates on planes have long proved among the most contentious of pandemic-era rules. Cabins have turned into breeding grounds for conflict, often over the necessity of wearing face coverings.

Polling from March found that Americans are close to evenly divided in their support for a continuing mask mandate for travel.

In a March 15-22 poll from the Kaiser Family Foundation, US adults were split on the federal mandate requiring people to wear masks on airplanes, trains and other public transportation. About half, 51%, said the government should let the mandate expire after April 18 (as it was originally set to do), while another 48% wanted to see the mask mandate for travel extended.

The same March poll found broader support for voluntary mask wearing in some situations. A 59% majority of Americans said that “people should continue to wear masks in some public places to minimize the spread of COVID-19 and avoid another surge in cases,” while 40% said that “people should stop wearing masks in most public places so things can get back to normal.”

About two-thirds of Americans are vaccinated with at least their initial series and less than a third have received their boosters. But many are signaling that they are ready to move on and live with the virus — with only 1 in 10 calling the pandemic a crisis in a recent Axios-Ipsos poll.

Reported cases of coronavirus, meanwhile, are rising in more than half of the 50 states, largely driven by the BA.2 omicron subvariant. But Covid-19 hospitalizations are close to their lowest level since the government began tracking that metric in July 2020. The BA.2 subvariant of Omicron and its offshoots are now causing virtually all cases of Covid-19 in the US.

When asked if the White House is concerned whether the administration being out of step with the American public’s perception of Covid-19, Psaki told reporters on Tuesday, “(W)e don’t make these decisions based on politics or based on the political whims on a plane or even in a poll.”

She argued that “there are still a lot of people in this country who still want to have masks in place,” pointing to immunocompromised individuals and parents with young children.

Biden administration looks for a return to normal — on its terms

In some ways, lifting the mask requirement on planes, trains and buses was a natural step for a White House intent on returning life to normal.

A few hours before the ruling on Monday, Biden was greeting 30,000 guests on the South Lawn for a revived Easter Egg Roll in Washington, the largest event he’s hosted at the executive mansion since taking office.

Even amid a spike in cases within his circle and among high-profile officials in Washington over the last month, Biden hadn’t altered his routines. And even his top aides had begun conceding that in a different phase of the pandemic, it was entirely possible he becomes infected himself.

Biden will headline two high-dollar fundraisers in the Pacific Northwest when he visits at the end of this week, according to people familiar with the plans — his first time hitting the road to raise money since taking office. He’d avoided in-person fundraising events for much of his presidency and campaign amid the pandemic.

The fundraisers are the latest signal the White House is moving to a post-pandemic normal. They will support the Democratic Grassroots Victory Fund, which is a joint account between the Democratic National Committee and state democratic parties.

Biden is otherwise using his trip to promote his infrastructure law. It will be only his second time on the West Coast since entering office.

CNN’s Ariel Edwards-Levy, Brenda Goodman, Maeve Reston, DJ Judd, Virginia Langmaid and Betsy Klein contributed to this report.

Read original article here

FDA-Approved Drug May Help Revive Vision in People With Progressive Blinding Disorders

A mouse retinal ganglion cell (green), which becomes hyperactive in degenerative vision disorders. Other retinal cell types are labeled in blue. Hyperactivity interferes with the proper transfer of signals from the retina to the brain. Richard Kramer’s lab at UC Berkeley has discovered what causes hyperactivity and has identified drugs that interfere with the process, and by doing so, improve vision. Credit: Shubhash Yadav, Richard Kramer lab, UC Berkeley

Test of drug could prove role of hyperactive retinal cells in blindness, potentially leading to better therapies.

Researchers at the (function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.6"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Read original article here

Biden to revive Obama-era plan to ‘end cancer as we know it’ – US politics live | US news

Barack Obama has channeled John Kennedy’s space race with the Russians to pledge a new “moonshot”, led by vice-president Joe Biden at “mission control”, for the United States to win a new global health race and find a cure for cancer.

“Last year, vice-president Biden said that with a new moonshot, America can cure cancer,” Obama said during a standout new policy moment during his final State of the Union address on Tuesday, referencing Biden’s remarks in announcing he would not run for president. “Last month, he worked with this Congress to give scientists at the National Institutes of Health the strongest resources they’ve had in over a decade.

“Tonight, I’m announcing a new national effort to get it done. And because he’s gone to the mat for all of us on so many issues over the past 40 years, I’m putting Joe in charge of Mission Control. For the loved ones we’ve all lost, for the family we can still save, let’s make America the country that cures cancer once and for all.” …

Inspired and led by Biden, who lost his eldest son, Beau, to brain cancer last year, the White House’s bold pledge follows the path laid forward by the vice-president when he declined to run to replace Obama in the White House.

“I’m going to spend the next 15 months in this office pushing as hard as I can to accomplish this,” Biden said from the White House Rose Garden in October. “Because I know there are Democrats and Republicans on the Hill who share our passion, our passion to silence this deadly disease.”

“If I could have been anything, I would have wanted to be the president that ended cancer,” Biden added. “Because it’s possible.”

Read original article here

The HRT face cream that claims to revive your skin

Who in midlife wants younger-looking skin? Quite a few of us, judging by the global anti-ageing industry — which will be worth an estimated £60.7 billion in 2022, according to market research firm Statista. We’re all looking for that magical potion that rolls back the years.

Well, hot flush! I mean, news flash! I may have found it.

Dr Marion Gluck is the world’s leading pioneer of the use of bio-identical hormones (chemically identical to the ones your body produces) to rebalance your own and improve well-being.

She trained as a doctor in Hamburg more than 30 years ago, and is founder of the private Marion Gluck Clinic in London, which is popular with celebrities seeking hormone replacement therapy (HRT) or hormone-balancing therapy.

Dr Marion Gluck (pictured), who is the world’s leading pioneer of the use of bio-identical hormones, has created a customised hormone facial cream

Now she has created a customised hormone facial cream — let’s call it HRT for the face.

Only available on private prescription as it is essentially a medicine, the Estra-, Estri- & Pro-Radiance Formula Range contains either the active bio-identical hormones oestrogen (in varying strengths as estriol or estradiol) or progesterone, plus other skin-friendly ingredients.

It sounds amazing — an elixir of youth, in a pot. Could it be a game-changer?

I’m excited, and only a little sceptical. Many women take systemic HRT (i.e. HRT that travels through your bloodstream) to offset the symptoms of the menopause. Aged 52, I’m one of them.

But while oestrogen gel and a progesterone pill daily boost my energy and focus, disappointingly, they haven’t done much for my skin. It’s dryer than it was five years ago and has lost elasticity — if I sleep on a creased pillow, the indentation on my cheek remains until lunchtime.

I book a consultation with Dr Valeria Acampora, hormone specialist and skin specialist at The Marion Gluck Clinic in London, and Dr Gluck herself.

Dr Acampora explains: ‘In peri-menopause and menopause our hormones oestrogen, progesterone and testosterone decline. Apart from general health, this also affects our skin, which becomes crepey and sagging, and then dry.’

Women may develop pigmentation and spots. And these aren’t just cosmetic issues, she says.

Anna Maxted (pictured) had a consultation with Dr Valeria Acampora, hormone specialist and skin specialist at The Marion Gluck Clinic in London, and Dr Gluck herself

‘We want flawless beautiful skin, but these are actually diseases. When our skin becomes wrinkled it becomes weak; our epidermis becomes thinner. Medically speaking it’s also a sign our skin is not as healthy as when we were younger.’

As for why my systemic HRT hasn’t rejuvenated my skin, Dr Acampora says: ‘When we are menopausal, our body is really craving hormones. All the hormones we take systemically are kept mainly by the vital organs, the brain, the bones and the heart, and the quantity that reaches the skin might not be enough.

‘Latest scientific studies have shown that we also need to apply hormones locally. And we add some antioxidants, anti-pigment and other molecules that help with dryness to create a product tailored to that patient’s specific needs.’

But can’t I just dot some of my systemic oestrogen gel on my face? Please don’t, says Dr Gluck aghast — it’s alcohol-based, not for sensitive skin and could even cause pigmentation.

Could there be a problem with double-dosing, as it were?

She reassures me: ‘It’s absolutely fine if you are on HRT. We are using topical hormones in very low doses, and we take everything into account during your consultation. It is not one or the other.’ Great news. So how do ‘hormoneceuticals’ improve our skin?

It seems cells in our dermis called fibroblasts which contribute to skin health become lazy as we age. Progesterone and oestrogen stimulate these skin cells to work.

Anna (pictured right) was prescribed the Pro-Radiance and the stronger oestrogen Estra‑Radiance to be used on alternate days

Dr Gluck adds: ‘We know if we have too much oestrogen, we become bloated.’ As in premenstrual syndrome, for example. ‘The reason being that oestrogen attracts fluid. But it’s actually very nice if we put a little oestrogen on our face — it attracts fluid and the skin plumps up a bit.’

While these unique formulations of HRT for the face are new, Dr Gluck notes: ‘The knowledge that topical hormones are good for the skin, and the science behind it, has been there for a long time.’ When Dr Gluck was a medical student in Germany working on hospital delivery wards, placentas were frozen and sold to the beauty industry (until the 1970s when regulations changed), as they contain progesterone.

While it’s not compulsory, she encourages patients to have blood tests to check their hormone levels. A peri-menopausal patient might only need the Pro-Radiance, as progesterone is the first hormone to decline; a post-menopausal woman might require the stronger oestrogen.

I’m prescribed the Pro-Radiance and the stronger oestrogen Estra‑Radiance (they’re very low dosage, so they don’t become systemic) to be used on alternate days. Dr Acampora explains how she’ll create my cream: ‘I will start with a base made specifically for dehydrated skin because of the decline of hormones. I will add some vitamin C — you don’t have a significant pigmentation problem, but it will help prevent any further pigmentation. It’s a powerful antioxidant so will also help with the skin ageing process which we can slow down. I will also add a little bit of retinol [vitamin A].’

The cost for a three-month supply is around £90 and mine is delivered a few days later.

Anna (pictured) was told by Dr Acampora that it will take around three more months for her fine lines to improve 

It’s certainly a simple routine. I apply one blob every evening before bed (alternating between oestrogen one day and progesterone the next) after washing my face. I don’t use any other product and, after six weeks, I look undeniably fresher-faced and my skin is dewier.

At a follow-up consultation, Dr Acampora says it will take around three more months for my fine lines to improve.

While the difference isn’t huge, my skin has acquired luminosity. I check this improvement regularly in the mirror but it’s a constant. My only worry, I tell Dr Acampora, is that when I use lip balm for a week, once I stop using it, my lips become even dryer. Would that happen with my hormone facial cream? No, she says.

In the cosmetic industry, she explains, many skincare products formulated to attract water sit on the surface of the skin. ‘So the top layer of our skin becomes very moisturised and sends a signal to the fibroblasts — which produce hyaluronic acid and hydrate the skin from within — “Oh she puts a lot of water on me, I have enough. Don’t produce water from inside.” So from putting on all these skincare products, our skin becomes dryer and dryer.’

‘Our physiological mechanism is the opposite,’ she says. ‘It starts from within. Hormones and vitamin A don’t hydrate your epidermis, they mainly penetrate the dermis and stimulate the fibroblasts to be more active. The fibroblasts need to be trained. Then our skin becomes healthy. It’s the gym for our skin.’

It surely is, because I’m starting 2022 with a glowing complexion that belies the psychological ravages of the last 18 months. And, as Dr Gluck says: ‘If you look good, you feel good. If you feel good, you look good.’

Happy New Year indeed!

Read original article here

Apple Wants to Revive AirPower With True Wireless Charging

Image: Apple

AirPower may not be as dead as we thought. Years after canceling the product, Apple is reportedly working on a new charger that could charge three devices at the same time.

According to Mark Gurman’s “Power On” newsletter for Bloomberg, the charger could include short and long-distance wireless charging technology so i-devices could eventually “charge each other.” Apple’s phones and accessories don’t even support reverse wireless charging, so if the company can bring this mystery device to market, it could potentially leap ahead of competitors in an area where it currently lags behind.

In June, Bloomberg reported on Apple developing a multi-device inductive charger back as a spiritual successor to AirPower. The earlier report said Apple was experimenting with sending power over the air for true wireless charging, not the sort-of wireless pad-style charging we use today. Making the technology mainstream would be similar to how AirPods popularized truly wireless earbuds when those awkward neckband earbuds (I know, I know, they’re good for fitness) were being lumped into the same category. Unfortunately, Bloomberg warned that any viable true wireless charging product is many years away.

If these reports are accurate, Apple will need to get this one right. Apple’s inability to bring AirPower to market after teasing the concept at its iPhone X event in 2017 will go down as one of the company’s most embarrassing failures. Excitement about a product that could simultaneously charge three or more products quickly dwindled as horror stories of development troubles, ranging from overheating to interference issues, surfaced. Apple eventually canceled the product in 2019, vaguely citing difficulties in creating a product that reached its unspecified standards.

Apple has since released less ambitious versions of AirPower, including the MagSafe Duo charger for juicing up two devices (iPhone, Apple Watch, AirPods charging case) at once. While useful for those invested in Apple’s MagSafe accessories, the Duo has been criticized for its slow charging speeds, flimsy build, and exorbitant price when compared with cheaper yet more capable third-party options.

Details on this rumored AirPower successor are thin apart from it charging at least three devices and potentially introducing true wireless charging. We don’t have specific on when Apple intends on bringing this product to market or what sort of charging speeds the company hopes to achieve.

We do know, however, that Apple is deeply committed to moving everything wireless, and various reports suggest the company could even abandon the charging port on upcoming iPhone models. We’ll be keeping a close eye out for any developments to see if Apple can recharge its AirPower project, though we’re not expecting any teasers or announcements until the company is sure it can even make the thing.

Read original article here

Konami is set to revive Metal Gear, Castlevania and Silent Hill

Konami [137 articles]” href=”https://www.videogameschronicle.com/companies/konami/”>Konami is set to ramp up its premium game development with new instalments and remakes for its biggest franchises, including Metal Gear and Castlevania.

That’s according to publishing sources who spoke to VGC anonymously, because they did not have permission to discuss their projects publicly.

Konami’s original games output has slowed down significantly in recent years. The last new Metal Gear game was 2018’s critically panned Metal Gear Survive, while the last mainline Castlevania release was 2014’s Lord of Shadow 2.

In the past decade, the company has arguably grown a bigger reputation for its Pachinko gambling games, than for its premium PC [4,043 articles]” href=”https://www.videogameschronicle.com/platforms/pc/”>PC and console releases.

However, following a restructure to the company’s game development divisions earlier this year, Konami is now focused on bringing back its biggest brands to the premium games space, VGC was told.

The first of these titles will be a new Castlevania game, which sources described as a “reimagining” of the series currently in development internally at Konami in Japan, with support from local external studios.

There’s been much speculation that Demon’s Souls [74 articles]” href=”https://www.videogameschronicle.com/games/demons-souls/”>Demon’s Souls studio Bluepoint Games [23 articles]” href=”https://www.videogameschronicle.com/companies/bluepoint/”>Bluepoint could be working on a remake of Metal Gear Solid. However, VGC was told the series is actually being worked on by an external studio based in Singapore.

Developer Virtuous worked on the Nintendo Switch [1,986 articles]” href=”https://www.videogameschronicle.com/platforms/nintendo/switch/”>Switch ports of Dark Souls Remastered [6 articles]” href=”https://www.videogameschronicle.com/games/dark-souls-series/dark-souls-remastered/”>Dark Souls Remastered, The Outer Worlds [67 articles]” href=”https://www.videogameschronicle.com/games/the-outer-worlds/”>The Outer Worlds and The BioShock Collection, as well as contributing art and content to blockbusters such as Battlefield 1, Uncharted (series) [145 articles]” href=”https://www.videogameschronicle.com/games/uncharted-series/”>Uncharted 4 and Horizon Zero Dawn [116 articles]” href=”https://www.videogameschronicle.com/games/horizon-zero-dawn/”>Horizon Zero Dawn.

The remake project is currently in early development and multiple sources suggested it would be centred around fan-favourite entry Metal Gear Solid 3: Snake Eater, rather than the original MGS.

Konami also intends to release remasters of the original Metal Gear Solid games for modern consoles, ahead of the larger project, we understand.

Finally, multiple Silent Hill games are currently in development at various external development studios, as per an earlier VGC report from February.

One of these projects was outsourced to a prominent Japanese developer earlier this year, we were told.

Multiple Silent Hill games are in the works.

Konami should publicly showcase its plans at major shows next year, disruption from the pandemic permitting. Konami pulled out of this year’s E3 2021 [63 articles]” href=”https://www.videogameschronicle.com/events/e3/e3-2021/”>E3 2021 show due to “timing” issues, although at the time it confirmed it had “a number of key projects” in the works.

Konami’s Japanese bosses are understood to have historically pushed back against most pitches to outsource its key games brands, which is a big reason why previous pitches for Silent Hill games, such as one by Until Dawn studio Supermassive, weren’t greenlit.

However, following the disappointing performance of recent in-house titles Metal Gear Survive and Contra: Rogue Corps, VGC’s sources said the company has become more willing to contract outside studios for its major franchises.

VGC first reported Konami’s softening of its stance over licensing its game properties earlier this year, in a report revealing that the company has outsourced a new Silent Hill game.

Last year, Konami ramped up its game efforts with the creation of a new external publishing programme, with which it hoped to sign more Western-developed titles.

Read original article here

The Ultimate News Site